Autoimmune Technologies is categorized under Medical Research in New Orleans, LA and active since 1995.
Autoimmune Technologies was established in 1995, and today employs 1 to 4, earning Unknown per year. This is a Medical Research business, which does work in the B2B market, and is classified as a Medical Research, under code number 5413802 by the NAICS.
If you are seeking more information, feel free to contact Russell Wilson, President at the company’s single location by writing to 1010 Common St # 1705, New Orleans, Louisiana LA 70112 or by phoning (504) 529-9944. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Autoimmune Technologies |
| Contact Person: | Russell Wilson, President |
| Address: | 1010 Common St # 1705, New Orleans, Louisiana 70112 |
| Phone Number: | (504) 529-9944 |
| Website Address: | autoimmune.com |
| Annual Revenue (USD): | Unknown |
| Founded: | 1995 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2B (Business to Business) |
| Business Category: | Medical Research |
| SIC Code: | 8733 |
| NAICS Code: | 5413802 |
| Share This Business: |
Autoimmune Technologies was started in 1995 to provide professional Medical Research under the SIC code 8733 and NAICS code 5413802. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of Unknown per annum.
Feel free to contact Russell Wilson, President for inquiries that concern Autoimmune Technologies by calling the company number (504) 529-9944, as your correspondence is most welcome. Additionally, the physical location of the single location of Autoimmune Technologies can be found at the coordinates 29.953837,-90.073006 as well as the street address 1010 Common St # 1705 in New Orleans, Louisiana 70112.
For its online presence, you may visit Autoimmune Technologies’s website at autoimmune.com and engage with its social media outlets through on Twitter and on Facebook.